Endometrial Cancer - LOHP Alone and With 5FU

Summary

To determine the efficacy (response rate \[RR\], time to progression and survival) of oxaliplatin as a single agent and oxaliplatin in combination with 5 FU in patients with advanced/metastatic endometrial cancer pretreated with one prior chemotherapy regimen containing cisplatin (CDDP) or carboplatin and to define the safety profile of each arm of the above mentioned regimens in these patients

Timeline

Start

2001-01

Primary completion

—

Completion

2005-03

Drugs

Indications